Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Ischemia
Description
A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. MeSH
Hierarchy View
Subtype Terms (3)
Chronic Limb-Threatening Ischemia
70 drugs (26 approved, 44 experimental)
Infarction
4 drugs (3 approved, 1 experimental)
No-Reflow Phenomenon
8 drugs (6 approved, 2 experimental)
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (15)
Other Experimental Indicated Drugs (13)
Organization Involved with Phase 4 Indications (215)
Ankara Yildirim Beyazıt University
ANMCO Italian Association of Hospital Cardiologist
Beijing Bionovo Medicine Development Co., Ltd.
Boryung Pharmaceutical Company
Canadian Anesthesiologists' Society
Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine
CardioVascular Research Foundation, Korea
Chengdu University of Traditional Chinese Medicines
China Academy of Chinese Medical Sciences
Clinical Institute of the Brain, Russia
Clinica Universidad de Navarra
Federal University of Rio Grande do Sul
Federation of Associations of Hospital Doctors on Internal Medicine (FADOI) Foundation
Fundação de Amparo à Pesquisa do Estado de São Paulo
Guangdong Provincial Hospital of Traditional Chinese Medicine
Guangzhou Baiyunshan Qixing Pharmaceutical Co Ltd
Guangzhou University of Chinese Medicine
Helena Laboratories Point of Care
Hoosier Cancer Research Network
Hospital Alessandro Manzoni Lecco
Huazhong University of Science and Technology
Hubei University of Chinese Medicine
Human Stem Cell Institute, Russia
Hunan Academy of Chinese Medicine
Hunan University of Traditional Chinese Medicine
Icahn School of Medicine at Mount Sinai
idv Datenanalyse und Versuchsplanung
I.M. Sechenov First Moscow State Medical University
Italian Society of Invasive Cardiology
Jiangmen Wuyi Hospital of Traditional Chinese Medicine
Jiangsu Kanion Pharmaceutical Co., Ltd
Liaoning Hospital of Traditional Chinese Medicine
Liling Hospital of Traditional Chinese Medicine
National Cerebral and Cardiovascular Center
National Cheng Kung University
National Heart, Lung, and Blood Institute (NHLBI)
Network for Clinical Stroke Trials
Neuro-Ophthalmologic Associates, PC
People's Liberation Army of China
Pontificia Universidad Catolica de Chile
Retina Macula Specialists of Miami, LLC
Shaanxi Provincial People's Hospital
Shaanxi University of Chinese Medicine
Shahid Beheshti University of Medical Sciences
Shandong University of Traditional Chinese Medicine
Shanghai Municipal Science and Technology Commission
Shanghai University of Traditional Chinese Medicine
Shanxi College of Traditional Chinese Medicine
Shin Kong Wu Ho-Su Memorial Hospital
Taipei Veteran General hospital
Texas Cardiac Arrhythmia Institute
The NO.4 People's Hospital of Hengshui
Tianjin University of Traditional Chinese Medicine
Tianshui Hospital of Traditional Chinese Medicine
University Hospital of Limerick
University of California, San Francisco
University of Campania Luigi Vanvitelli
University of Modena and Reggio Emilia
University of Roma La Sapienza
University of Southern California
University of Texas at Houston
University of Western Australia
Vita-Salute University of Milano. Italy
Wuxi Hospital of Traditional Chinese Medicine
Organization Involved with Phase 3 Indications (229)
Atrium Medisch Centrum, Heerlen
Beijing Northland Biotech. Co., Ltd.
Boston Health and Hospitals Department
Canadian Institutes of Health Research (CIHR)
Canadian Stroke Consortium (CSC)
Centers for Disease Control and Prevention (CDC)
Chinese Academy of Medical Sciences
Clinical Research Centre Hospital Taiping
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Dexa Laboratories Of Biomolecular Science
Djavad Mowafaghian Centre for Brain Health
Dr. Negrin University Hospital
Duta Wacana Christian University
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
Fondazione Mediolanum per Attività e Ricerche Cardiovascolari Onlus
Fundación Canaria de Investigación Sanitaria
German Federal Ministry of Education and Research
Greater Baltimore Medical Center
Hamilton Health Sciences Corporation
Helsingin Ja Uudenmaan Sairaanhoitopiirin
Hospital Santa Marcelina, Sao Paulo, Brasil
Indonesia's Neurologists Organization (Perdossi)
Katholieke Universiteit Leuven
King Faisal Specialist Hospital
Korea Institute of Science and Technology
Maryland Medical Research Institute
Mazandaran University of Medical Sciences
Medical University of South Carolina
Mt. Sinai Medical Center, Miami
National Cancer Institute (NCI)
National Health and Medical Research Council, Australia
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Aging (NIA)
National Institutes of Health (NIH)
Neurological Emergencies Treatment Trials Network
New England Research Institutes
Oklahoma Medical Research Foundation
Pacific Health Research Institute
Palo Alto Medical Research Foundation
Pirogov Russian National Research Medical University
Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC)
Salt Lake Clinic Research Foundation
Science Valley Research Institute
Seberang Jaya Clinical Research Centre
Servicio de Evaluación. Servicio Canario de Salud. Spain
Simcere Pharmaceutical Co., Ltd
St. Joseph Hospital Health Center
Technical University of Dresden
The Stroke Association, United Kingdom
The University of Texas, Dallas
University Hospital of North Norway
University of Alabama, Birmingham
University of British Columbia
University of California, Davis
University of California, Los Angeles
University of California, San Diego
University of Erlangen-Nuremberg
University of Las Palmas de Gran Canaria
University of North Carolina at Chapel Hill
University of Science Malaysia
Virginia Commonwealth University
Organization Involved with Phase 2 Indications (196)
All India Institute of Medical Sciences
Amrita Institute of Medical Sciences
Andalusian Initiative for Advanced Therapies
Andalusian Initiative in Advanced Therapies
Angde Biotech Pharmaceutical Co., Ltd.
Aristotle University of Thessaloniki
Badalona Hospital Germans Trias i Pujol
Bhagwan Mahaveer Jain Hospital
Bharat Biotech International Limited
Cardiovascular Cell Therapy Research Network
Case Western Reserve University
Chandler Regional Medical Center at Chandler AZ
City Hospital No 40, Saint Petersburg, Russia
Essential Pharmaceuticals, LLC
Etablissement Français du Sang
Fibrex Medical Research & Development GmbH
First People's Hospital of Foshan
Foundation for Biomedical Research and Innovation
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
General Hospital of Armed Police, Beijing
Guangzhou Recomgen Biotech Co., Ltd.
Hunan Rui Kang Tong technology development co., LTD
Inner Mongolia Baogang Hospital
Institut National de la Santé Et de la Recherche Médicale, France
Ivy Institute of Stem Cells Co. Ltd
Jaslok Hospital and Research Centre, Mumbai, India
Kokilaben Dhirubai Ambani Hospital
Kyunghee University Medical Center
Melaka Manipal Medical College
M.S. Ramaiah Medical College, Bangalore, India
MultiGene Vascular Systems Ltd.
National University of Malaysia
Oregon Health and Science University
Rawalpindi Institute of Cardiology
Rubens Siqueira Research Center
Shifa Tameer-e-Millat University
Shijiazhuang Pharma Group (CSPC)
South China Research Center for Stem Cell and Regenerative Medicine
Sri Ganga Ram Hospital, New Delhi
Sri Jayadeva Institute of Cardiovascular Sciences & Research
Sri Ramachandra Medical College, Chennai
Sygnis Bioscience GmbH & Co KG
The Florey Institute of Neuroscience and Mental Health
The Florey Institute of Neuroscience & Mental Health Melbourne Brain Centre
The University of Texas Health Science Center, Houston
Thrombolytic Science International
Translational Research Informatics Center, Kobe, Hyogo, Japan
Universidad Autonoma de Barcelona
Universidad Autonoma de Madrid
University of California, Irvine
Organization Involved with Phase 1 Indications (53)
Beytepe Murat Erdi Eker State Hospital
China Spinal Cord Injury Network
Chinese University of Hong Kong
Dow University of Health Sciences
Greater Houston Retina Research
Hospital Hernando Moncaleano Perdomo
Hospital Universitario Hernando Moncaleano Perdomo
KK Women's and Children's Hospital
Organization Involved with Other Experimental Indications (56)
Albert Einstein Israelite Hospital
Bethune International Peace Hospital
Centro Cardiologico Monzino IRCCS
Heart and Stroke Foundation of Canada
Hospital Israelita Albert Einstein
Institute of Liver and Biliary Sciences, India
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
